{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:49:25Z","timestamp":1771919365696,"version":"3.50.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Before surgery and other invasive treatments, decisions must be made on whether to discontinue drugs and provide appropriate drug holidays especially for antithrombotic drugs, and this is made difficult by the large number of available drugs and associated guidelines. We have therefore developed an online application for perioperative drug discontinuation and resumption management, named Saga Application for Management of Drug Holidays in PeriOperative Periods (SAMPOP).<\/jats:p>\n            <jats:p>Multidisciplinary medical staff at Saga University Hospital (SUH) worked together to build an evidence-based Perioperative Drug Discontinuation Management Database (PDDMD) and developed the user-friendly SAMPOP online application via preliminary verification at SUH. From September 2018 to February 2020, 420 medical staff at SUH, including physicians, nurses, and pharmacists, installed and tested SAMPOP.<\/jats:p>\n            <jats:p>Rate per surgical procedure for forgetting to discontinue antithrombotic drugs preoperatively decreased from 0.18% to 0.09% as of August 2019, 12 months after the introduction of SAMPOP (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.1359). In addition, six months later, it decreased further to 0.03% as of February 2020 (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.0436). Forgetting to resume antithrombotic drugs postoperatively decreased from 0.20% to 0.02% as of August 2019, 12 months after the introduction of SAMPOP (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.0008). There was no case of forgetting to resume the medication in the last 6 months.<\/jats:p>\n            <jats:p>SAMPOP may be useful for management of drug holidays in the clinic and warrants further evaluation of its safety and efficacy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000020142","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:37:20Z","timestamp":1588970240000},"page":"e20142","source":"Crossref","is-referenced-by-count":7,"title":["Development of an application for management of drug holidays in perioperative periods"],"prefix":"10.1097","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1717-6208","authenticated-orcid":false,"given":"Sakiko","family":"Kimura","sequence":"first","affiliation":[{"name":"Safety Management Section, Saga University Hospital"},{"name":"Dep. of Pharmacy, Saga University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Emoto","sequence":"additional","affiliation":[{"name":"Dep. of Pharmacy, Saga University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Safety Management Section, Saga University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Arimizu","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Saga University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Kamura","sequence":"additional","affiliation":[{"name":"Dep. of Pharmacy, Saga University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rintaro","family":"Sogawa","sequence":"additional","affiliation":[{"name":"Dep. of Pharmacy, Saga University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kikumi","family":"Mizuta","sequence":"additional","affiliation":[{"name":"Safety Management Section, Saga University Hospital"},{"name":"Department of Nursing, Saga University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Tagomori","sequence":"additional","affiliation":[{"name":"Safety Management Section, Saga University Hospital"},{"name":"Department of Nursing, Saga University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Natsuaki","sequence":"additional","affiliation":[{"name":"Div. of Cardiovascular Medicine, Dep. of Internal Medicine, Faculty of Medicine, Saga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Kajiwara","sequence":"additional","affiliation":[{"name":"Div. of Cardiovascular Medicine, Dep. of Internal Medicine, Faculty of Medicine, Saga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanae","family":"Tsuruoka","sequence":"additional","affiliation":[{"name":"Div. of Gastrointestinal Endoscopy, Dep. of Internal Medicine, Faculty of Medicine, Saga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Yakushiji","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine, Faculty of Medicine, Saga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Tanigawa","sequence":"additional","affiliation":[{"name":"Surgical Center, Saga University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Takamatsu","sequence":"additional","affiliation":[{"name":"Safety Management Section, Saga University Hospital"},{"name":"Surgical Center, Saga University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Danjo","sequence":"additional","affiliation":[{"name":"Dep. of Oral and Maxillofacial Surgery, Faculty of Medicine, Saga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Kamohara","sequence":"additional","affiliation":[{"name":"Dep. of Thoracic and Cardiovascular Surgery, Faculty of Medicine, Saga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Hirakawa","sequence":"additional","affiliation":[{"name":"Dep. of Anesthesiology and Critical Care Medicines, Faculty of Medicine, Saga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Sakaguchi","sequence":"additional","affiliation":[{"name":"Dep. of Anesthesiology and Critical Care Medicines, Faculty of Medicine, Saga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Dep. of Urology, Faculty of Medicine, Saga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Noshiro","sequence":"additional","affiliation":[{"name":"Dep. of Surgery, Faculty of Medicine, Saga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Saga University Hospital"},{"name":"Center for Comprehensive Community Medicine, Faculty of Medicine, Saga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisaburo","family":"Sueoka","sequence":"additional","affiliation":[{"name":"Dep. of Clinical Laboratory Medicine, Faculty of Medicine, Saga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Narisawa","sequence":"additional","affiliation":[{"name":"Dep. of Pharmacy, Saga University Hospital"},{"name":"Div. of Dermatology, Dep. of Internal Medicine, Faculty of Medicine, Saga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Kimura","sequence":"additional","affiliation":[{"name":"Safety Management Section, Saga University Hospital"},{"name":"Clinical Research Center, Saga University Hospital"},{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,5]]},"reference":[{"key":"R1-20240308","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/den.12183","article-title":"Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment","volume":"26","author":"Fujimoto","year":"2014","journal-title":"Dig Endosc"},{"key":"R2-20240308","first-page":"567","article-title":"Guidelines for management of anticoagulant and antiplatelet therapy in cardiovascular disease (JCS 2009)","volume":"69","author":"Murasaki","year":"2011","journal-title":"Nihon Rinsho"},{"key":"R3-20240308","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1253\/circj.CJ-66-0092","article-title":"Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013)","volume":"78","year":"2014","journal-title":"Circ J"},{"key":"R4-20240308","first-page":"1","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS","volume":"0","author":"Valgimigli","year":"2017","journal-title":"Eur Heart J"},{"key":"R5-20240308","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","article-title":"Update European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation","volume":"17","author":"Heidbuchel","year":"2015","journal-title":"Europace"},{"key":"R6-20240308","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4244\/EIJV10I1A8","article-title":"Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies","volume":"10","author":"Rossini","year":"2014","journal-title":"Eurointervention"},{"key":"R7-20240308","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jacc.2016.11.024","article-title":"2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation","volume":"69","author":"Doherty","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R12-20240308","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1182\/blood-2011-02-329979","article-title":"Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach","volume":"117","author":"James","year":"2011","journal-title":"Blood"},{"key":"R15-20240308","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/bjs.9485","article-title":"Perioperative management of patients on new oral anticoagulants","volume":"101","author":"Lai","year":"2014","journal-title":"Br J Surg"},{"key":"R16-20240308","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/ALN.0b013e318289bcba","article-title":"Managing new oral anticoagulants in the perioperative and intensive care unit setting","volume":"118","author":"Levy","year":"2013","journal-title":"Anesthesiology"},{"key":"R17-20240308","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/EJA.0b013e32833f6f6f","article-title":"European Society of Anaesthesiology. Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology","volume":"27","author":"Gogarten","year":"2010","journal-title":"Eur J Anaesthesiol"},{"key":"R18-20240308","doi-asserted-by":"crossref","first-page":"i96","DOI":"10.1093\/bja\/aer381","article-title":"Regional anaesthesia in the patient receiving antithrombotic and antiplatelet therapy","volume":"107","author":"Horlocker","year":"2011","journal-title":"Br J Anaesth"},{"key":"R19-20240308","first-page":"e1044","article-title":"Dental management in patients with antiplatelet therapy: a systematic review","volume":"1","author":"S\u00e1ez-Alcaide","year":"2017","journal-title":"J Clin Exp Dent"},{"key":"R20-20240308","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00784-018-2576-x","article-title":"Local haemostatic measures after tooth removal in patients on antithrombotic therapy: a systematic review","volume":"23","author":"Ockerman","year":"2019","journal-title":"Clin Oral Investig"},{"key":"R21-20240308","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/ageing\/afq059","article-title":"Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA2DS2\u2013VASc risk stratification scores","volume":"39","author":"Pamukcu","year":"2010","journal-title":"Age Ageing"},{"key":"R22-20240308","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1212\/01.WNL.0000118288.04483.02","article-title":"Antiplatelet drug discontinuation is a risk factor for ischemic stroke","volume":"62","author":"Sibon","year":"2004","journal-title":"Neurology"},{"key":"R23-20240308","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1093\/eurheartj\/ehl334","article-title":"A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease","volume":"27","author":"Biondi-Zoccai","year":"2006","journal-title":"Eur Heart J"},{"key":"R24-20240308","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1161\/CIRCULATIONAHA.106.686048","article-title":"Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment","volume":"116","author":"Airoldi","year":"2007","journal-title":"Circulation"},{"key":"R25-20240308","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1215637","article-title":"Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia","volume":"369","author":"Byrd","year":"2013","journal-title":"N Engl J Med"},{"key":"R26-20240308","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/jamadermatol.2017.1877","article-title":"Association of Ibrutinib treatment with bleeding complications in cutaneous surgery","volume":"153","author":"Parra","year":"2017","journal-title":"JAMA Dermatol"},{"key":"R28-20240308","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1182\/blood-2014-06-583294","article-title":"Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions","volume":"124","author":"Levade","year":"2004","journal-title":"Blood"},{"key":"R29-20240308","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/leu.2014.247","article-title":"Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation","volume":"4","author":"Kamel","year":"2015","journal-title":"Leukemia"},{"key":"R30-20240308","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1470-2045(09)70222-0","article-title":"Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials","volume":"10","author":"Je","year":"2009","journal-title":"Lancet Oncol"},{"key":"R31-20240308","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1470-2045(09)70341-9","article-title":"Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care","volume":"4","author":"Bose","year":"2010","journal-title":"Lancet Oncol"},{"key":"R32-20240308","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1634\/theoncologist.2010-0271","article-title":"Noncardiac vascular toxicities of vascular endothelial growth factor inhibitors in advanced cancer: a review","volume":"16","author":"Keefe","year":"2011","journal-title":"Oncologist"},{"key":"R33-20240308","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R34-20240308","first-page":"S1","article-title":"Anti-TNF alpha therapy and safety monltoring. Clinical tool guide elaborated by the Club Rhumatismes et lnflammations (CRI), section of the French Society of Rheumatology (Societ6 Frangaise de Rhumatologie, SFR)","volume":"72","author":"Pham","year":"2005","journal-title":"Joint Bone Spine"},{"key":"R36-20240308","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1056\/NEJMra1309483","article-title":"Lactic Acidosis","volume":"371","author":"Kraut","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T20:12:39Z","timestamp":1709928759000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":28,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000020142","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}